2nd International Congress and Exhibition Pharma Uzbekistan & Central Asia
15-16 November 2023, Tashkent, Uzbekistan
15-16 November 2023, Tashkent, Uzbekistan
Pharma Uzbekistan & Central Asia Congress and Exhibition is a unique international platform for leaders of the pharmaceutical industry of Uzbekistan, Kazakhstan, Tajikistan and other countries of Central Asia which involves senior executives of investment projects and major pharmaceutical plants, government officials, regulators, technology licensors, developers, manufacturers and suppliers of equipment, engineering and construction companies, technology and service providers. The event is devoted to discussion of major investment projects on construction of production capacities, to efficiency boosting options of pharmaceuticals production.
First Deputy Director
Agency for the Development of the Pharmaceutical Industry under the Ministry of Environmental Protection of Uzbekistan
First Deputy Director
Agency for the Development of the Pharmaceutical Industry under the Ministry of Environmental Protection of Uzbekistan
Director
the Institute of the Chemistry of Plant Substances, Academy of Sciences of Uzbekistan
Director
the Institute of the Chemistry of Plant Substances, Academy of Sciences of Uzbekistan
Head of Strategy Department
SK-Pharmacy
Deputy Director
Agency for Attracting Foreign Investment under the Ministry of Investment and Foreign Trade of the Republic of Uzbekistan
Deputy Director
Agency for Attracting Foreign Investment under the Ministry of Investment and Foreign Trade of the Republic of Uzbekistan
Business Development Director
Person Hunters LTD
Head of Division in Uzbekistan
Bayer CH
CEO
Eurasian Academy of Good Practices
Head
Analytical Instrumentation Consortium – Technology Transfer – Uzbekistan
Head of Scientific Laboratory
Research and Production Centre for Cultivation and Processing of Medicinal Plants under the State Forestry Committee
Head of Scientific Laboratory
Research and Production Centre for Cultivation and Processing of Medicinal Plants under the State Forestry Committee
Deputy Director
Directorate of Innovation Research and Production Pharmaceutical Cluster Tashkent Pharmapark
Deputy Director
Directorate of Innovation Research and Production Pharmaceutical Cluster Tashkent Pharmapark
Deputy CEO for Quality
Baxtteks-Farm
Head of Pharmacovigilance Department
State Centre for Expertise and Standardisation
Head of Pharmacovigilance Department
State Centre for Expertise and Standardisation
INNOVATIVE RESEARCH AND PRODUCTION PHARMACEUTICAL CLUSTER TASHKENT PHARMA PARK (PHASE 1)
Operator/initiator: Pharmaceutical Industry Development Agency of the Republic of Uzbekistan
Location: Tashkent region, Zangiatinsky district, Uzbekistan
Stage: July 2021 – the main parameters of the feasibility study were set
Dates: Commissioning is expected in November 2024
Investment amount: 130,2 million US dollars
The project is developed to incentivise integrated development of the pharmaceutical industry in the Republic, including through expansion of product portfolio of medical preparations, R&D, and personnel training in accordance with international educative standards.
The project is financed through EDCG funds Eximbank of Korea, UFRD, support and development of the pharmaceutical industry and direct foreign investment. The modular structure of the cluster with a total area of 50 ha implies establishment of industrial, academic, R&D, clinical and pre-clinical sectors.
On the territory of the cluster there will be production sites to produce innovative medical devices and equipment, multi-functional research university and its components, R&D centres, public expertise centre for pharmaceutical products, a datacentre, and other required infrastructure.
PRODUCTION OF SUBSTANCES AND MEDICAL PREPARATIONS IN THE FORM OF PILLS, CAPSULES, INJECTIONS (3 PHASES)
Operator/initiator: Cadila Pharmaceuticals Uzbekistan
Location: Andizhan region, Uzbekistan
Dates: Commissioning:
phase 1 – November 2023;
phase 2 – October 2024;
phase 3 – November 2024
Investment amount: 50 million US dollars
The Indian Cadila Pharmaceuticals Ltd. concluded an investment agreement with the Ministry of Investment and Foreign Trade of Uzbekistan on establishment of a pharmaceutical plants in the free economic zone named Andizhan-farm.
It is planned to attract direct foreign investment in 2020‑2025 valued at $50m with at least $10m to be allocated in 2020‑2021 to develop phase 1 of the project; to generate 400 new job opportunities; establishment of a modern system for pharmaceuticals production and quality management in line with international standards.
30 items of drugs and medical devices will be registered on an expedited basis with no fee charging for registration certificate.
PRODUCTION OF MEDICAL PREPARATIONS IN THE FORM OF PILLS AND CAPSULES
Operator/initiator: Solyphar Laboratories
Location: Tashkent region, Bostanlyk district, Uzbekistan
Dates: Commissioning is expected in November 2023
Investment amount: Over 20 million US dollars
In the Bostanlyk district of the Tashkent region it is expected to launch the construction of a factory to produce medical preparations valued at 20 million US dollars. It is expected that annual production capacity will be 500 million pills, 200 million capsules, 10 million sachets (powder). It is planned to release over 120 types of medical preparations. Solyphar is one of the leading players on the pharmaceutical market of Egypt which is also engaged in international collaborations.
The project implies construction of a pharmaceutical factory in the free economic zone territory located in the Bostanlyk district of the Tashkent region. This convenient location is provided with all the required infrastructure enabling to cut expenses on logistics and resource provision. This Uzbekistan’s project is the first large project which involves direct investment by Solyphar abroad. This new production will comply with the requirements of the proper production practice – GMP. To ensure high quality of products Solyphar is active in cooperating with the German International Quality Consulting (IQC) Group.
PRODUCTION OF MEDICAL PREPARATIONS TO CURE DIABETES
Operator/initiator: Multi Fruite Korea
Location: Samarkand region, Samarkand district, Uzbekistan
Dates: Commissioning is expected in November 2024
Investment amount: 20 million US dollars
Projected nameplate capacity is 275 tonnes. The project is expected to generate 150 job opportunities.
PRODUCTION OF SOLID MEDICAL PREPARATIONS AND CARBAPENEMS
Operator/initiator: Belpharm
Location: Tashkent, Unusabad district, Uzbekistan
Dates: Commissioning is expected in November 2024
Investment amount: 10 million US dollars
Within the framework of agreements with the Uzbekistan’s government in September 2018, there was a decision made on construction of a modern pharmaceutical plant in association with
foreign investors.
The plant will comply with the requirements of the international GMP standard. The company named Belpharm was established in January 2019 and started the development of that project in
October 2019.
Projected launch of Phase 1 is Q1 2021; Phase 2 – Q1 2024.
PRODUCTION OF MEDICAL PRODUCTS (MEDICAL GAUZES AND BANDAGES)
Operator/initiator: Radiks
Location: Tashkent region, Bostanlyk district, Uzbekistan
Dates: Commissioning is expected in November 2023
Investment amount: 7,70 million US dollars
Projected nameplate capacity is 25 million pcs. The project is expected to generate 30 job opportunities.
350+ SENIOR EXECUTIVES OF THE LARGEST PHARMACEUTICAL COMPANIES will gather together on one site to discuss the thorny issues in the industry!
ONSITE VISIT to Nika Pharm production site. A tour to workshops and labs, showcase of equipment.
20+ REPORTS with unique information from senior executives of key companies in the industry.
65+ LARGEST PROJECTS OF INDUSTRY LEADERS. Presentation of the development stages of the largest investment projects in the pharmaceutical industry of Uzbekistan.
TRENDS 2022. CONSTRUCTION AND MODERNISATION OF PHARMACEUTICAL PLANTS: state support measures, foreign investments, new and existing projects. How does the pharmaceutical industry live in Uzbekistan today?
DEVELOPMENT OF PRODUCTION FACILITIES. Introduction of the best practices in construction of new facilities and modernisation of existing ones: the experience of pharmaceutical companies in Uzbekistan, advantages, challenges, and phases.
CONSTRUCTION. Construction projects for pharmaceutical companies. What to consider when developing project documentation? What are the steps from design to commissioning?
TECHNOLOGIES. How to choose the required equipment for a specific production? How to choose and determine the need for auxiliary equipment? How to validate a ready for use facility?
CASE STUDIES. Case studies on modernising pharmaceutical plants in Uzbekistan. What are the methods of increasing the company efficiency? How to choose the best method for your company?
DESIGN AND LAYOUT. How to properly ensure industrial safety at a production site? What are the requirements for fire safety at production and how to meet them?
CHANGE OF PROFILING: From food supplements to medicines. Experience of other companies in the industry. What are the aspects of registration, standards of manufacturing, storage, and logistics of medicines?
INVESTMENTS. What are the methods of attracting foreign investors? What is necessary to consider when working with foreign investors?
SERIALIZATION, BRANDING, AGGREGATION: cutting-edge technologies and process optimization.
EXCLUSIVE EXHIBITION AND TECHNOLOGICAL PRESENTATIONS. Technological presentations, road shows, specialised exhibition of technologies, equipment, and services from world leaders.
30+ HOURS OF BUSINESS COMMUNICATION AND NETWORKING! One-on-one meetings, business lunches, coffee breaks, cocktail reception and many others.
Source Photo:
Industry Report
Overview of the industry status and prospects for the development of the pharmaceutical industry in the Republic of Uzbekistan
